Evaluating the Association between CCR5delta32 Polymorphism (rs333) and the Risk of Breast Cancer in a Cohort of Iranian Population

Evaluating the Association between CCR5delta32 Polymorphism (rs333) and the Risk of Breast Cancer in a Cohort of Iranian Population

Background: CC chemokine receptor 5 (CCR5) is introduced as an immune response modulator. The activity of CCR5 influences breast tumour development in a p53-dependent manner. This study aimed to investigate the frequency of CCR5delta32 and its association with the risk of breast cancer in 1038 blood...

Full description

Bibliographic Details
Main Authors: Amir TAJBAKHSH, Zahra FARJAMI, Abolfazl NESAEI-BAJESTANI, Fahimeh AFZALJAVAN, Mahdi RIVANDI, Atefeh MOEZZI, Soheila ABEDINI, Mahla ASGHARI, Mohammad Mahdi KOOSHYAR, Fatemeh HOMAEI SHANDIZ, Alireza PASDAR
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2021-02-01
Series:Iranian Journal of Public Health
Subjects:
CCR5D32
p53 pathway
Breast carcinoma
Immunogenetics
Metastasis
Online Access:https://ijph.tums.ac.ir/index.php/ijph/article/view/17576

Internet

https://ijph.tums.ac.ir/index.php/ijph/article/view/17576

Similar Items